4CMenB vaccine for gonorrhea

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 4 Jun 2020: Trial registered, NCT04415424
  2. 8 Jul 2021: Trial started, NCT04415424
  3. 13 Mar 2023: Trial registered, NCT05766904
  4. 4 May 2023: Trial started, NCT05766904

The trials

NCT04415424: Efficacy Study of 4CMenB (Bexsero®) to Prevent Gonorrhoea Infection in Gay and Bisexual Men

State
Under way
Phase
Phase 3
People
650 taking part
Started
8 Jul 2021
Primary completion
30 Jun 2025
Arms
Treatment arm A - 4CMenB vaccine
Results
None posted
  1. 4 Jun 2020: Trial registered
  2. 8 Jul 2021: Trial started

NCT05766904: Efficacy Trial on Meningococcal B Vaccine for Preventing Gonorrhea Infections

State
Under way
Phase
Phase 3
People
150 planned
Started
4 May 2023
Primary completion
Sep 2026
Arms
Intervention
Results
None posted
  1. 13 Mar 2023: Trial registered
  2. 4 May 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.